Scientific article
Open access

Current landscape of palliative radiotherapy for non-small-cell lung cancer

Published inTranslational lung cancer research, vol. 8, no. S2, p. S192-S201
Publication date2019-09
First online date2019-09

Radiotherapy (RT) is a cornerstone in the management of advanced stage III and stage IV

non-small-cell lung cancer (NSCLC) patients. Despite international guidelines, clinical practice remains

heterogeneous. Additionally, the advent of stereotactic ablative RT (SABR) and new systemic treatments

such as immunotherapy have shaken up dogmas in the approach of these patients. This review will focus on

palliative thoracic RT for NSCLC but will also discuss the role of stereotactic radiotherapy, endobronchial

brachytherapy (EBB), the interest of concomitant treatments (chemotherapy and immunotherapy), and the

role of RT in lung cancer emergencies with palliative intent.

Affiliation Not a UNIGE publication
Citation (ISO format)
JUMEAU, Raphael et al. Current landscape of palliative radiotherapy for non-small-cell lung cancer. In: Translational lung cancer research, 2019, vol. 8, n° S2, p. S192–S201. doi: 10.21037/tlcr.2019.08.10
Main files (1)
Article (Published version)
ISSN of the journal2218-6751

Technical informations

Creation06/26/2023 10:01:43 PM
First validation11/14/2023 10:31:15 AM
Update time11/14/2023 10:31:15 AM
Status update11/14/2023 10:31:15 AM
Last indexation02/01/2024 11:01:04 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack